We analyzed the mex3a mRNA expression level in cases of BLCA and evaluated its prognostic value and whether mex3a could be a biomarker and a potential therapeutic target in high-risk BLCA. The gene discussed is MEX3A; the disease is bladder transitional cell carcinoma.